Hemolytic Anemia Due to Glucose-6-Phospate Dehydrogenase Deficiency in Neonate

Authors

  • Syahrurrahman Syahrurrahman Department of Pediatric, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
  • Nadirah Rasyid Ridha Department of Pediatric, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
  • Adhariana H Kaddas Department of Pediatric, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
  • Mokhammad Ikhsan Nurkholis Department of Pediatric, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia

DOI:

https://doi.org/10.33096/gmj.v6i1.150

Keywords:

Hemolytic anemia, glucose-6-Phosphate dehydrogenase, neonates

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme in erythrocytes that functions to maintain glycolysis, form an erythrocyte membrane, and protect hemoglobin from oxidative denaturation. Clinical manifestations of anemia and severe jaundice are risk factors for acute hyperbilirubinemia encephalopathy, which can progress to kernicterus. G6PD deficiency is X-linked. The incidence is most common in males with an incidence in Indonesia of 1-14%.

 

A 3-day-old male baby appeared yellowish and had a history of being pale since 1 day of age. There was a history of phototherapy and packed red blood cell transfusion from a previous hospital. The baby was born via caesarean section, term baby, with a birth weight of 2700 grams. The Physical examination revealed Kramer V, tachypnea, but no hepatosplenomegaly. A previous laboratory examination at AM Hospital showed total bilirubin of 23.3 mg/dL, indirect bilirubin 23 mg/dL, and pre-transfusion hemoglobin 9.8 g/dL. Chest X-rays revealed grade I–II hyaline membrane disease. Meanwhile, the laboratory test results at the Dr Wahidin Sudirohusodo Hospital showed a total bilirubin of 38.5 mg/dL, indirect bilirubin 37.17 mg/dL, reticulocytes 9.95%, hemoglobin 11.8 g/dL, CRP 5.2 mg/L, Procalcitonin 0.5 ng/mL, and a negative Coombs test. The peripheral blood smear showed fragmented cells of erythrocytes. The G6PD level was 17.2 U/dL (reference value >20.5 U/dL). The patient received low-flow oxygenation, antibiotics, and 72 hours of intensive phototherapy. On the 7th day of treatment, the condition improved, and the baby was discharged. Therefore, Rapid diagnosis and treatment of G6PD deficiency are important to prevent other potential complication such as acute hyperbilirubinemia encephalopathy. 

References

Timan IS, Pattiasina F, Pasaribu MM, et al. G6PD Deficiency in Indonesian Newborn. Adv Sci Lett. 2018;24(9):6602-6604. doi:10.1166/asl.2018.12792

Gomella TL. Gomella, T.C., Cunningham, M.D., Eyal, F.G. Neonatologi Management, Procedures, On-Call Problems, Disease, and Drugs. 7th Edition. New York: Mc Graw-Hill. In: ; 2013:558-567.

Rahardjani KB. Kadar Bilirubin Neonatus dengan dan Tanpa Defisiensi Glucose-6-Phosphate Dehydrogenase yang Mengalami atau Tidak Mengalami Infeksi. Sari Pediatr. 2008;10(2):122. doi:10.14238/sp10.2.2008.122-8

Kurniawan L. Coninuing Medical Education: Skrining , Diagnosis dan Aspek Klinis Defisiensi. CDK. 2014;41(11):807-811.

Sari T, Muhaimin R, Fazlurrahman U. Hemolytic disease of newborn: fokus pada inkompatibilitas ABO. J Kedokt Syiah kuala. 2021;21(2):197-203.

Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A, Cheah FC. Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity. Front Pediatr. 2022;10(May):1-13. doi:10.3389/fped.2022.875877

Sumathipala S. Glucose-6-Phosphate Dehydrogenase Deficiency : A Review. World Fam Med Journal/Middle East J Fam Med. 2020;18(9):92-97. doi:10.5742/mewfm.2020.93862

Frank JE. Diagnosis and management of G6PD deficiency. Am Fam Physician. 2005;72(7):1277-1282.

Volney G, Tatusov M, Yen AC, Karamyan N. Naphthalene toxicity: methemoglobinemia and acute intravascular hemolysis. Cureus. (2018) 10:e3147. doi: 10.7759/cureus.3147.

de Gurrola GC, Araúz JJ, Durán E, Aguilar-Medina M, Ramos-Payán R, García-Magallanes N, et al. Kernicterus by glucose-6-phosphate dehydrogenase deficiency: a case report and review of the literature. J Med Case Rep. (2008) 2:146. doi: 10.1186/1752-1947- 2.

Dogra N, Puri GD, Rana SS. Glucose-6-phosphate dehydrogenase deficiency and cardiac surgery. Perfusion. 2010;25(6):417-421. doi:10.1177/0267659110380770

Luzzatto L, Nannelli C, Notaro R. Glucose-6-Phosphate Dehydrogenase Deficiency. Hematol Oncol Clin North Am. 2016;30(2):373-393. doi:10.1016/j.hoc.2015.11.006

Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubi- naemia: a global perspective. Lancet Child Adolesc Health 2018; 2:610–620. doi: 10.1016/S2352-4642(18)30139-1.

American Academy of Pediatrics Subcommittee on Hyperbilirubi- nemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316. doi: 10.1542/peds.114.1.297.

Zhang M, He Y, Tang J, et al. Intensive phototherapy vs . exchange transfusion for the treatment of neonatal hyperbilirubinemia : a multicenter retrospective cohort study. 2022;135(5). doi:10.1097/CM9.0000000000001962

Downloads

Published

2024-04-01